BioSpace News Archive

Natus Medical Incorporated today announced financial results for the three and nine months ended September 30, 2021.

Neoleukin Therapeutics, Inc., today announced financial results and a corporate update for the third quarter ended September 30, 2021.

Viridian Therapeutics, Inc. today announced financial results for the third quarter ended September 30, 2021, and provided corporate updates.

Assertio Holdings, Inc., a leading commercial pharmaceutical company bringing differentiated products to patients, reported financial results for the third quarter ended September 30, 2021.

PROCEPT® BioRobotics Corporation, a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, reported financial results for the quarter ended September 30, 2021.

Loxo Oncology at Lilly , a research and development group of Eli Lilly and Company (NYSE: LLY), today announced that study investigators will present data from the pirtobrutinib development program at the American Society of Hematology (ASH) Annual Meeting to be held December 11-14, 2021

Grifols, a leading global producer of plasma-derived medicines, announced the launch of its latest albumin portfolio innovation, ALBUTEIN FlexBag™ in 5% and 25% concentrations.

CTI BioPharma Corp. (Nasdaq: CTIC) today announced five poster presentations from the Company’s pacritinib program at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition, being held virtually and in Atlanta, Georgia , December 11-14, 2021 .

Actinium Pharmaceuticals, Inc. announced multiple abstracts highlighting its Iomab-B and Actimab-A clinical programs have been accepted for presentation at the 63 American Society of Hematology Annual Meeting being held in person and virtually in Atlanta, Georgia, December 11 – 14, 2021.

MEI Pharma, Inc., a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced that three abstracts highlighting data and information from three oncology drug candidates in its pipeline will be presented at the upcoming 63rd Annual American Society of Hematology Annual Meeting to be held December 11 – 14, 2021.